業務
貨幣單位:美元
2024/FY
名稱營收比例
Human immunodeficiency virus (HIV)6,080.4萬32.72%
Sample Management Solutions5,104.6萬27.47%
Coronavirus disease 2019 (COVID-19)4,517.2萬24.31%
Hepatitis C virus (HCV)1,402.4萬7.55%
Risk assessment testing835.4萬4.50%
Other product and service revenues350.6萬1.89%
Molecular Services170.5萬0.92%
Non-product and services revenues121.6萬0.65%
查看全部
地區
貨幣單位:美元
2024/FY
名稱營收比例
美國1.39億74.89%
非洲3,274.5萬17.62%
歐洲842.4萬4.53%
其他地區549.7萬2.96%